Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Mol Cell Cardiol. 2010 Jul 8;49(5):728–736. doi: 10.1016/j.yjmcc.2010.06.012

Figure 7.

Figure 7

in vivo study of effect of CGP-37157 on ouabain-induced arrhythmia: A. representative traces of surface ECG recorded at different time points: baseline (upper), after ouabain administration (middle), and after isoproterenol administration (lower). B. heart rate at baseline, after ouabain administration, and after isoproterenol administration with (n=5) or without (n=5) pretreatment of CGP-37157. C. incidence of PVB after the administration of isoproterenol. In the group of iso, animals (n=4) were only administrated with 0.25mg/kg iso without pretreatment of ouabain.